Biotech Network Saxony

11.02.2010

TRM LEIPZIG AIMS TO COMBAT MULTIPLE SCLEROSIS BY REGENERATING NERVE CELLS

Multiple sclerosis (MS) is a particularly insidious disease. Sufferers, who are frequently young adults, are usually beset by neurological symptoms such as impaired vision and deteriorating motor skills occurring in phases. They are caused by an inflammation which damages the protective myelin sheaths around the axons of the brain and the spinal cord.

The medicines mainly used at present curb the inflammation and help slow down the disease. However, there are no effective drugs yet which can regenerate damaged myelin sheaths. To rectify this, TRM Leipzig is now supporting a study into a new type of MS therapy.

 

More information…

Back to overview